Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FDG-PET/CT”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07770672
What this trial is testing

An Exploratory Clinical Study of Accurate Efficacy Assessment of Neoadjuvant Immunotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma Based on 68Ga-FAPI ([68Ga] Fibroblast Activation Protein Inhibitor)/¹⁸F-FDG (2-Deoxy-2-[¹⁸F]Fluoro-D-glucose) Dual Imaging

Who this might be right for
Esophageal CancerESCC
Tan Lijie 92
Not applicableStudy completedNCT02043444
What this trial is testing

Secretory Azoospermia and FDG (Fluoro Deoxyglucose) PET-CT

Who this might be right for
Fertility
University Hospital, Toulouse 160
Not applicableLooking for participantsNCT07398300
What this trial is testing

Insulin-Mediated Glucose Uptake and Organ Perfusion Assessed by Total-Body PET During GIP and GLP-1 Infusion

Who this might be right for
Type 2 DiabetesHealhty
Rigshospitalet, Denmark 36
Not applicableUnknownNCT03051555
What this trial is testing

18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Natural Killer/T-cell Lymphoma

Who this might be right for
Lymphoma, Extranodal NK-T-Cell
Peking University Cancer Hospital & Institute 60
Not applicableStudy completedNCT04512118
What this trial is testing

CT Abnormalities Evocative of Lung Infection Are Associated With Lower 18F-FDG Uptake in Confirmed COVID-19 Patients

Who this might be right for
Presence of COVID-19 Compatible CT Abnormalities
Central Hospital, Nancy, France 22
Not applicableStudy completedNCT03914950
What this trial is testing

TOF-18F-FDG-PET/CT in Patients With Suspected Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatitisIPMN
Medical University of Graz 174
Not applicableStudy completedNCT02372890
What this trial is testing

Validation of High-resolution PET/CT for the Pretherapeutic Lymphnode Staging of Head/Neck Cancer

Who this might be right for
Otorhinolaryngeal NeoplasmsCancer of Head and Neck
Insel Gruppe AG, University Hospital Bern 153
Not applicableUnknownNCT02599974
What this trial is testing

PET-CT in the Initial Staging of Breast Cancer and in the Early Assessment of Response to Neoadjuvant Chemotherapy

Who this might be right for
Breast CancerPositron-Emission Tomography
Assistance Publique - Hôpitaux de Paris 400
Not applicableStudy completedNCT07712172
What this trial is testing

Assessing Granulomatosis With Polyangiitis Activity: 18F-FDG PET/CT vs BVAS v3

Who this might be right for
Granulomatosis With Polyangiitis (Wegener's)
Post Graduate Institute of Medical Education and Research, Chandigarh 31
Not applicableUnknownNCT04214353
What this trial is testing

PSMA-PET Imaging Before and After ADT in Advanced SDC Patients

Who this might be right for
Salivary Gland CancerSalivary Duct Carcinoma
Radboud University Medical Center 14
Not applicableUnknownNCT03051542
What this trial is testing

Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Natural Killer/T-cell Lymphoma

Who this might be right for
Lymphoma, Extranodal NK-T-Cell
Peking University Cancer Hospital & Institute 60
Post-approval studies (Phase 4)UnknownNCT02621541
What this trial is testing

Nonfunctional Pancreatic NET and PET Imaging

Who this might be right for
Diagnosis
Turku University Hospital 20
Large-scale testing (Phase 3)Ended earlyNCT00522639
What this trial is testing

Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation

Who this might be right for
Lung CancerSCLCNSCLC
Maastricht Radiation Oncology 120
Not applicableUnknownNCT03572595
What this trial is testing

F-18 FDG- PETCT in Staging and Recurrent Colorectal Cancer

Who this might be right for
Colo-rectal CancerRecurrence
Assiut University 45
Not applicableStudy completedNCT02144311
What this trial is testing

Benchmarking Intra-tumor Heterogeneity In Ovarian Cancer: Linking In-vivo Imaging Phenotypes With Histology And Genomics

Who this might be right for
Ovarian Cancer
Memorial Sloan Kettering Cancer Center 26
Not applicableStudy completedNCT02378337
What this trial is testing

Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality

Who this might be right for
Malignant Neoplasm of BreastHodgkin DiseaseNon-Hodgkin Lymphoma, Follicular (Nodular)+5 more
Hospital Sao Rafael 335
Testing effectiveness (Phase 2)Ended earlyNCT04631601
What this trial is testing

Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Amgen 55
Not applicableStudy completedNCT05270967
What this trial is testing

FDG (Fluorodeoxyglucose) Findings After COVID-19 Vaccination

Who this might be right for
Vaccine ReactionOncology
Kocaeli University 129
Not applicableLooking for participantsNCT05873777
What this trial is testing

68Ga-FAPI-LM3 PET/CT Imaging in Patients With FAP/SSTR2 Positive Disease and Compared With 18F-FDG

Who this might be right for
SSTR2FAPPositron-Emission Tomography
The First Affiliated Hospital of Xiamen University 30
Testing effectiveness (Phase 2)Study completedNCT01565200
What this trial is testing

HER2 Imaging Study to Identify HER2 Positive Metastatic Breast Cancer Patient Unlikely to Benefit From T-DM1

Who this might be right for
HER-2 Positive Breast Cancer
Jules Bordet Institute 90
Next Page